Sonoma Pharmaceuticals, Inc.
SNOA · XNASCIK 1367083fmd_1MK3KXMQQSRYZX4CDWS28YEJXQManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Apr 01, 2010 to Sep 30, 2026, 66 periods
Sonoma Pharmaceuticals, Inc. (SNOA) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2026 | FY2025 | Change | Source |
|---|---|---|---|---|
| Revenue | $19.5 million | $14.3 million | +36.7% | 10-K 2026-06-16 · proof |
| Gross profit | $7.4 million | $5.5 million | +35.7% | 10-K 2026-06-16 · proof |
| Operating income | -$2.5 million | -$3.7 million | 10-K 2026-06-16 · proof | |
| Net income | -$3.2 million | -$3.5 million | 10-K 2026-06-16 · proof | |
| Cash from operating activities | -$3.9 million | -$88,000 | 10-K 2026-06-16 · proof | |
| Free cash flow | -$4.1 million | -$168,000 | 10-K 2026-06-16 · proof | |
| Total assets | $14 million | $13.7 million | +1.9% | 10-K 2026-06-16 · proof |
| Total liabilities | $10.9 million | $9.3 million | +17.1% | 10-K 2026-06-16 · proof |
| Cash and cash equivalents | $2.4 million | $5.4 million | -55.4% | 10-K 2026-06-16 · proof |
- What was Sonoma Pharmaceuticals, Inc. (SNOA)'s revenue in fiscal 2026?
- Sonoma Pharmaceuticals, Inc. (SNOA) reported revenue of $19.5 million for fiscal 2026 (the year ended Mar 31, 2026), against $14.3 million the year before (+36.7%). Source: the 10-K filed with the SEC on Jun 16, 2026. SEC
- What was Sonoma Pharmaceuticals, Inc. (SNOA)'s gross profit in fiscal 2026?
- Sonoma Pharmaceuticals, Inc. (SNOA) reported gross profit of $7.4 million for fiscal 2026 (the year ended Mar 31, 2026), against $5.5 million the year before (+35.7%). Source: the 10-K filed with the SEC on Jun 16, 2026. SEC
- What was Sonoma Pharmaceuticals, Inc. (SNOA)'s operating income in fiscal 2026?
- Sonoma Pharmaceuticals, Inc. (SNOA) reported operating income of -$2.5 million for fiscal 2026 (the year ended Mar 31, 2026), against -$3.7 million the year before. Source: the 10-K filed with the SEC on Jun 16, 2026. SEC
- What was Sonoma Pharmaceuticals, Inc. (SNOA)'s net income in fiscal 2026?
- Sonoma Pharmaceuticals, Inc. (SNOA) reported net income of -$3.2 million for fiscal 2026 (the year ended Mar 31, 2026), against -$3.5 million the year before. Source: the 10-K filed with the SEC on Jun 16, 2026. SEC
- What was Sonoma Pharmaceuticals, Inc. (SNOA)'s cash from operating activities in fiscal 2026?
- Sonoma Pharmaceuticals, Inc. (SNOA) reported cash from operating activities of -$3.9 million for fiscal 2026 (the year ended Mar 31, 2026), against -$88,000 the year before. Source: the 10-K filed with the SEC on Jun 16, 2026. SEC
- What was Sonoma Pharmaceuticals, Inc. (SNOA)'s free cash flow in fiscal 2026?
- Sonoma Pharmaceuticals, Inc. (SNOA) reported free cash flow of -$4.1 million for fiscal 2026 (the year ended Mar 31, 2026), against -$168,000 the year before. Source: the 10-K filed with the SEC on Jun 16, 2026. SEC
- What are Sonoma Pharmaceuticals, Inc. (SNOA)'s total assets?
- As of Mar 31, 2026, Sonoma Pharmaceuticals, Inc. (SNOA) reported total assets of $14 million, against $13.7 million a year earlier (+1.9%). Source: the 10-K filed with the SEC on Jun 16, 2026. SEC
- What are Sonoma Pharmaceuticals, Inc. (SNOA)'s total liabilities?
- As of Mar 31, 2026, Sonoma Pharmaceuticals, Inc. (SNOA) reported total liabilities of $10.9 million, against $9.3 million a year earlier (+17.1%). Source: the 10-K filed with the SEC on Jun 16, 2026. SEC
- What are Sonoma Pharmaceuticals, Inc. (SNOA)'s cash and cash equivalents?
- As of Mar 31, 2026, Sonoma Pharmaceuticals, Inc. (SNOA) reported cash and cash equivalents of $2.4 million, against $5.4 million a year earlier (-55.4%). Source: the 10-K filed with the SEC on Jun 16, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:SNOA&period_type=annual&limit=5"Information only, not investment advice.